Cardiovascular Disease | 1.91E−08 - 4.11E−02 | ELN, MLXIPL, NCF1, EIF4H, SLC6A4, BAZ1B, LIMK1 |
Developmental Disorder | 1.91E−08 - 4.11E−02 | ELN, MLXIPL, NCF1, PMS2, SLC6A4, LIMK1 |
Endocrine System Disorders | 1.91E−08 - 4.45E−02 | ELN, MLXIPL, PMS2, BAZ1B, CLDN3, LIMK1 |
Hereditary Disorder | 1.91E−08 - 3.77E−02 | ELN, MLXIPL, NCF1, SLC6A4, PMS2, AVPR1A, LIMK1 |
Organismal Injury and Abnormalities | 1.91E−08 - 4.11E−02 | ELN, NCF1, MLXIPL, LAT2, PMS2, TRPA1, SLC6A4, LIMK1 |
Renal and Urological Disease | 1.91E−08 - 1.9E−02 | ELN, MLXIPL, SLC6A4, LIMK1 |
Behavior | 1.16E−06 - 4.45E−02 | NCF1, SLC6A4, TRPA1, FZD9, STX1A, GTF2IRD1, AVPR1A, LIMK1 |